Advanced Search

 

Study ID Status Title Patient Level Data
HYT104152 Completed A Phase I Study to Characterize the Pharmacokinetics of Topotecan at 4 mg/m2 Administered Weekly as a 30-Minute Intravenous Infusion in Patients with Cancer
HYT105962 Completed A Randomized, Phase III, Open-Label Study of Oral Topotecan Plus Whole-Brain Radiation Therapy (WBRT) Compared with WBRT Alone in Patients with Brain Metastases from Non-Small Cell Lung Cancer
HYT109091 Completed A Phase I Open-label Study of the Safety, Tolerability, and Pharmacokinetics of Two Schedules of Oral Topotecan in combination with Pazopanib in Subjects with Advanced Solid Tumors
HZA102928 Completed A randomised, double blind, placebo controlled, parallel group, 14 day repeat dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled GW685698X containing magnesium stearate in healthy subjects Study Listed on ClinicalStudyDataRequest.com
HZA102940 Completed A randomised, double-blind, placebo-controlled, four-way crossover study to compare the pharmacodynamics and pharmacokinetics of GW685698X and GW642444M when administered separately and in combination as a single dose from a novel dry powder device in healthy japanese subjects Study Listed on ClinicalStudyDataRequest.com
HZA105871 Completed A randomised, double-blind, placebo-controlled, four-way crossover study to compare the pharmacodynamics and pharmacokinetics of GW685698X and GW642444M when administered separately and in combination as a single dose from a novel dry powder device in healthy subjects Study Listed on ClinicalStudyDataRequest.com
HZA108799 Completed A randomised, double blind, two-way crossover study, to examine the safety, tolerability, pharmacokinetics and pharmacodynamics of a single inhaled administration of GW685698X (800?g) with and without magnesium stearate, in mild/moderate asthmatic patients. Study Listed on ClinicalStudyDataRequest.com
HZA109895 Terminated An exploratory study to evaluate the response of salmeterol plus fluticasone propionate vs fluticasone propionate alone to experimental nasal inoculation with rhinovirus Study Listed on ClinicalStudyDataRequest.com
HZA109912 Completed A 12-week, randomised, double-blind, placebo-controlled, three-period, cross-over pilot study comparing the effect of salmeterol/fluticasone propionate, fluticasone propionate and placebo on perpheral blood eosinophils and serum IL-5 in response to allergen challenge in asthma subjects when allergen challenge is administered at 1 hour or 11-12 hours post-dose of the dosing interval Study Listed on ClinicalStudyDataRequest.com
HZC111348 Completed Study HZC111348, a repeat-dose study of GW685698/GW642444 Inhalation Powder versus Placebo in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
IBN104125 Completed See Detailed Description
IDB-200-001 Completed A Randomized, Double-Blind Trial Evaluating the Safety and Immunogenicity of an Influenza Vaccine with reduced Preservative (FluLaval™ TR) and a Standard Influenza Vaccine (Fluarix®) in subjects between 18-60 and Over 60 Years of Age. Study Listed on ClinicalStudyDataRequest.com
IDB-707-105 Completed Active-control study to evaluate the safety, tolerance and immunogenicity of Fluviral™ S/F influenza vaccine in healthy adults aged 18-64 years of age
IDB-707-106 Completed A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Fluviral™ Influenza Vaccine in Healthy Adults 18 to 49 Years of Age
IDB-707-107 Completed Clinical study to evaluate safety, tolerance and immunogenicity of Fluviral® trivalent split virion influenza vaccine (season 2005-2006) in adults aged between 18-60 and over 60
IDB-707-108 Completed Non-Inferiority Comparison of Fluviral™ Influenza Virus Vaccine to a US Licensed Inactivated Split-Virion Vaccine in Adults
IDB-707-109 Completed A Randomized, Double-blind Trial Comparing the Safety and Immunogenicity of Two Lots of Fluviral® Influenza Vaccine in Healthy Adults 18 to 49 Years of Age
IDB-707-110 Completed Clinical Study to Evaluate Safety, Tolerance and Immunogenicity of Fluviral® Trivalent Split Virion Influenza Vaccine (2006 – 2007 Season) in Adults Aged Between 18-60 and over 60
ILI105618 Completed A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18 (SB-485232) Administered by Intravenous Infusion in Combinationwith Rituximab in Adult Patients with B Cell Non-Hodgkin'sLymphoma" Study Listed on ClinicalStudyDataRequest.com
ILI108621 Completed A phase I, dose escalation study to assess the safety & biological activity of Interleukin 18 (SB-485232) administered by IV infusion in combination with pegylated liposomal doxorubicin (Doxil) in advanced stage epithelial ovarian cancer Study Listed on ClinicalStudyDataRequest.com
IMU40001 Completed A randomised, single-dose, three-way cross-over study evaluating the bioequivalence of 50 mg oral doses of the azathioprine formulation manufactured in Germany compared to the azathioprine formulations manufactured in France and UK in healthy volunteers.
IND/SEREACC/PMS Completed Post Marketing Surveillance (PMS) of salmeterol and fluticasone in fixed dose combination (Seretide® Accuhaler) in the Treatment of Bronchial Asthma.
India Flixonase PMS (no study number) Completed Title Post Marketing Surveillance of Flixonase (Fluticasone Propionate Aqueous Nasal Spray (FPANS)) to Evaluate the Safety of Fluticasone 200 micrograms (mcg) Nasal Spray in Indian Patients with Allergic Rhinitis
ING111207 Completed A Double-Blind, Randomized, Placebo-Controlled, Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1349572 in Healthy Subjects
ING111322 Completed See Study Description

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.